These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 38786020)

  • 1. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
    Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
    Cells; 2024 May; 13(10):. PubMed ID: 38786020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets.
    Czekay RP; Cheon DJ; Samarakoon R; Kutz SM; Higgins PJ
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.
    Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ
    J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.
    Mancarella S; Gigante I; Pizzuto E; Serino G; Terzi A; Dituri F; Maiorano E; Vincenti L; De Bellis M; Ardito F; Calvisi DF; Giannelli G
    J Exp Clin Cancer Res; 2024 Oct; 43(1):286. PubMed ID: 39415286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
    Mertens JC; Fingas CD; Christensen JD; Smoot RL; Bronk SF; Werneburg NW; Gustafson MP; Dietz AB; Roberts LR; Sirica AE; Gores GJ
    Cancer Res; 2013 Jan; 73(2):897-907. PubMed ID: 23221385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
    Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
    Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.
    Lobe C; Vallette M; Arbelaiz A; Gonzalez-Sanchez E; Izquierdo L; Pellat A; Guedj N; Louis C; Paradis V; Banales JM; Coulouarn C; Housset C; Vaquero J; Fouassier L
    Hepatology; 2021 Dec; 74(6):3194-3212. PubMed ID: 34297412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
    Ying F; Chan MSM; Lee TKW
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma.
    Zhang Y; Yan HJ; Wu J
    Curr Cancer Drug Targets; 2024; 24(7):681-700. PubMed ID: 38213139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma.
    Lewinska M; Zhuravleva E; Satriano L; Martinez MB; Bhatt DK; Oliveira DVNP; Antoku Y; Keggenhoff FL; Castven D; Marquardt JU; Matter MS; Erler JT; Oliveira RC; Aldana BI; Al-Abdulla R; Perugorria MJ; Calvisi DF; Perez LA; Rodrigues PM; Labiano I; Banales JM; Andersen JB
    Gastroenterology; 2024 May; 166(5):886-901.e7. PubMed ID: 38096955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Cholangiocarcinoma Immune Biology.
    Vita F; Olaizola I; Amato F; Rae C; Marco S; Banales JM; Braconi C
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma.
    Cantallops Vilà P; Ravichandra A; Agirre Lizaso A; Perugorria MJ; Affò S
    Hepatology; 2024 Apr; 79(4):941-958. PubMed ID: 37018128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
    Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B
    Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.
    Wang J; Ilyas S
    Expert Opin Investig Drugs; 2021 Apr; 30(4):429-438. PubMed ID: 33322977
    [No Abstract]   [Full Text] [Related]  

  • 20. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
    Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
    Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.